N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

NCT01260649 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class

Stopped lack of funding to cover staff salary (clinician and research coordinator)

Conditions

Interventions

Sponsor

Massachusetts General Hospital